Striverdi Respimat: once daily LABA for COPD

Olodaterol (Striverdi) is a new once-daily LABA formulated as a solution for use in the Respimat inhaler and is licensed as maintenance in COPD. Here, we present the clinical data relating to its efficacy and adverse events and comment on its place in therapy.

Striverdi Respimat once daily LABA for COPD

Add yours ↓
Web design and marketing agency Leamington Spa